149 related articles for article (PubMed ID: 32682252)
1. High need for sugammadex for rocuronium reversal with acute renal failure and normal need in the same patient with no renal impairment.
Valente A
J Clin Anesth; 2020 Dec; 67():109981. PubMed ID: 32682252
[No Abstract] [Full Text] [Related]
2. Does the pretreatment of magnesium sulphate affect the sugammadex reversal time for rocuronium-induced neuromuscular blockade? A meta-analysis.
Miao M; Zhang J
J Clin Anesth; 2020 Mar; 60():78-79. PubMed ID: 31476625
[No Abstract] [Full Text] [Related]
3. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
[TBL] [Abstract][Full Text] [Related]
4. Management of subcutaneous infiltration of rocuronium: A case report.
Timmermann TN; Mongan PD; Hoefnagel AL; Braunecker S
J Clin Anesth; 2021 Aug; 71():110203. PubMed ID: 33609852
[No Abstract] [Full Text] [Related]
5. No effect of intraoperative rocuronium doses on 30-day postoperative complications after sugammadex reversal in patients undergoing gastrointestinal surgery.
Onoe K; Ogata H; Ishimoto D; Kaneko T; Ueki R; Kariya N; Tatara T; Hirose M
J Clin Anesth; 2020 May; 61():109662. PubMed ID: 31759814
[No Abstract] [Full Text] [Related]
6. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
de Boer HD; van Egmond J; Driessen JJ; Booij LH
Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
[TBL] [Abstract][Full Text] [Related]
7. [Sugammadex, a novel drug for neuromuscular blockade reversal].
Fernández Meré LA; Alvarez-Blanco M
Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
[TBL] [Abstract][Full Text] [Related]
8. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex rescue following prolonged rocuronium neuromuscular blockade with 'recurarisation' in a patient with severe renal failure.
Lobaz S; Sammut M; Damodaran A
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396837
[TBL] [Abstract][Full Text] [Related]
11. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
13. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
[TBL] [Abstract][Full Text] [Related]
14. Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report.
Hung SK; Yeh CC; Ting PC; Chen CH; Kao MC
J Int Med Res; 2022 Jul; 50(7):3000605221113913. PubMed ID: 35869623
[TBL] [Abstract][Full Text] [Related]
15. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
16. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
19. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
Weekes G; Hayes N; Bowen M
Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
[TBL] [Abstract][Full Text] [Related]
20. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
Abad Gurumeta A; Gutiérrez García R
Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
